Co Diagnostics (Germany) Market Value
| C97 Stock | EUR 5.16 0.00 0.00% |
| Symbol | C97 |
Co Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Co Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Co Diagnostics.
| 12/15/2025 |
| 01/14/2026 |
If you would invest 0.00 in Co Diagnostics on December 15, 2025 and sell it all today you would earn a total of 0.00 from holding Co Diagnostics or generate 0.0% return on investment in Co Diagnostics over 30 days. Co Diagnostics is related to or competes with Cardinal Health, Mitsui Chemicals, Ares Management, and COMM HEALTH. Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic te... More
Co Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Co Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Co Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.4 | |||
| Information Ratio | 0.0514 | |||
| Maximum Drawdown | 333.46 | |||
| Value At Risk | (14.06) | |||
| Potential Upside | 14.29 |
Co Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Co Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Co Diagnostics' standard deviation. In reality, there are many statistical measures that can use Co Diagnostics historical prices to predict the future Co Diagnostics' volatility.| Risk Adjusted Performance | 0.0501 | |||
| Jensen Alpha | 2.0 | |||
| Total Risk Alpha | (2.07) | |||
| Sortino Ratio | 0.1642 | |||
| Treynor Ratio | (3.68) |
Co Diagnostics Backtested Returns
Co Diagnostics is abnormally volatile given 3 months investment horizon. Co Diagnostics retains Efficiency (Sharpe Ratio) of 0.056, which signifies that the company had a 0.056 % return per unit of price deviation over the last 3 months. We were able to interpolate twenty-four different technical indicators, which can help you to evaluate if expected returns of 2.15% are justified by taking the suggested risk. Use Co Diagnostics Coefficient Of Variation of 1855.46, market risk adjusted performance of (3.67), and Standard Deviation of 36.46 to evaluate company specific risk that cannot be diversified away. Co Diagnostics holds a performance score of 4 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -0.53, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Co Diagnostics are expected to decrease at a much lower rate. During the bear market, Co Diagnostics is likely to outperform the market. Use Co Diagnostics market risk adjusted performance, semi deviation, variance, as well as the relationship between the mean deviation and downside deviation , to analyze future returns on Co Diagnostics.
Auto-correlation | Huge |
Perfect predictability
Co Diagnostics has perfect predictability. Overlapping area represents the amount of predictability between Co Diagnostics time series from 15th of December 2025 to 30th of December 2025 and 30th of December 2025 to 14th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Co Diagnostics price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current Co Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 92233.7 T | |
| Spearman Rank Test | -0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Co Diagnostics lagged returns against current returns
Autocorrelation, which is Co Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Co Diagnostics' stock expected returns. We can calculate the autocorrelation of Co Diagnostics returns to help us make a trade decision. For example, suppose you find that Co Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Co Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Co Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Co Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Co Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Co Diagnostics Lagged Returns
When evaluating Co Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Co Diagnostics stock have on its future price. Co Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Co Diagnostics autocorrelation shows the relationship between Co Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Co Diagnostics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in C97 Stock
When determining whether Co Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Co Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Co Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Co Diagnostics Stock:Check out Co Diagnostics Correlation, Co Diagnostics Volatility and Co Diagnostics Alpha and Beta module to complement your research on Co Diagnostics. For more detail on how to invest in C97 Stock please use our How to Invest in Co Diagnostics guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Co Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.